Investment analysts at StockNews.com assumed coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Free Report) in a research report issued on Saturday. The firm set a “buy” rating on the medical instruments supplier’s stock.
Pro-Dex Price Performance
Pro-Dex stock opened at $17.23 on Friday. The stock has a market cap of $61.17 million, a price-to-earnings ratio of 13.57 and a beta of 0.97. The company has a debt-to-equity ratio of 0.36, a current ratio of 3.07 and a quick ratio of 1.58. Pro-Dex has a 1 year low of $14.47 and a 1 year high of $21.43. The firm has a 50-day moving average of $18.56 and a two-hundred day moving average of $17.29.
Institutional Investors Weigh In On Pro-Dex
Several hedge funds have recently modified their holdings of the business. Punch & Associates Investment Management Inc. lifted its position in shares of Pro-Dex by 13.5% in the 1st quarter. Punch & Associates Investment Management Inc. now owns 63,075 shares of the medical instruments supplier’s stock worth $1,035,000 after purchasing an additional 7,480 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Pro-Dex by 1.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 58,751 shares of the medical instruments supplier’s stock worth $920,000 after acquiring an additional 625 shares in the last quarter. LSV Asset Management raised its stake in shares of Pro-Dex by 13.9% during the 1st quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier’s stock worth $588,000 after acquiring an additional 4,346 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Pro-Dex by 59.2% during the 1st quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier’s stock worth $345,000 after acquiring an additional 7,762 shares in the last quarter. Finally, Northern Trust Corp raised its stake in shares of Pro-Dex by 4.1% during the 2nd quarter. Northern Trust Corp now owns 19,735 shares of the medical instruments supplier’s stock worth $377,000 after acquiring an additional 776 shares in the last quarter. Hedge funds and other institutional investors own 14.61% of the company’s stock.
About Pro-Dex
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Featured Stories
- Five stocks we like better than Pro-Dex
- What is a Bond Market Holiday? How to Invest and Trade
- Investing in Coffee: 3 Great Strategies to Consider
- What Are Defense Contractor Stocks? How to Invest in Defense
- 5 Best Stocks to Buy in a Bear Market
- How to Invest in Semiconductors
- 3 Pharmaceutical Stocks to Buy and Hold for the Long Haul
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
